Industry / Germany
Merck KGaA Divests In Primary Care Promotion
July 2008 | Industry NewsGermany's drug discount contracts - which enforce pharmacists to dispense drugs for which health insurers have arranged price reductions with pharmaceutical companies - appear to have caused one of the country's leading home-grown pharmaceutical companies drastically to reduce its presence in the domestic market. Merck KGaA is to disband a large proportion of its domestic primary care sales force as a result of what it describes as 'drastically changing marketing conditions'. At the start of August 2008, Merck will transfer 130 employees to rival Daiichi Sankyo's German operations, subject to contractual agreements between the employees and the Japanese firm. While
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
